Hu et al., (2016) reported that SPRY4-IT1 gene is overexpressed in the plasma of patients with NSCLC compared with healthy volunteers, and the amplification of SPRY4-IT1 in the plasma of patients with NSCLC is closely related to the tumor size. The gene discussed is SPRY4; the disease is neoplasm.